Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,540
-140 (-1.20%)
At close: May 9, 2025, 3:30 PM KST
-20.14%
Market Cap 176.18B
Revenue (ttm) 259.60B
Net Income (ttm) 23.38B
Shares Out 15.27M
EPS (ttm) 1,531.45
PE Ratio 7.54
Forward PE 8.56
Dividend 300.00 (2.57%)
Ex-Dividend Date Dec 27, 2024
Volume 13,931
Average Volume 11,736
Open 11,680
Previous Close 11,680
Day's Range 11,520 - 11,680
52-Week Range 10,530 - 15,900
Beta 0.33
RSI 51.29
Earnings Date May 2, 2025

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceuticals products in South Korea. The company offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1978
Employees 582
Stock Exchange Korea Stock Exchange
Ticker Symbol 016580
Full Company Profile

Financial Performance

In 2024, Whan In Pharm's revenue was 259.60 billion, an increase of 12.68% compared to the previous year's 230.39 billion. Earnings were 23.38 billion, a decrease of -21.47%.

Financial Statements

News

There is no news available yet.